Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-2-microglobulin in diseases with high bone remodeling

E Ripoll1, I Arribas, P Relea

  • 1Central Laboratory Príncipe de Asturias, University Hospital, University of Alcalá de Henares, Madrid, Spain.

Calcified Tissue International
|October 1, 1995
PubMed
Summary

Serum beta2-microglobulin shows potential as a bone remodeling marker in various diseases, but not Paget's disease. Tartrate-resistant acid phosphatase (TRAP) also indicated bone turnover differences across patient groups.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature.

Leukemia & lymphoma·2023
Same author

Uveitis intermedia as the initial presentation of a primary lymphoma of the central nervous system.

Archivos de la Sociedad Espanola de Oftalmologia·2022
Same author

Clinical characteristics, management, and one-year risk of complications among patients with heart failure with and without type 2 diabetes in Spain.

Revista clinica espanola·2021
Same author

Uveitis intermedia as the initial presentation of a primary lymphoma of the central nervous system.

Archivos de la Sociedad Espanola de Oftalmologia·2021
Same author

Towards the quantitative characterisation of piglets' robustness to weaning: a modelling approach.

Animal : an international journal of animal bioscience·2019
Same author

Association of genetic variants and expression levels of porcine FABP4 and FABP5 genes.

Animal genetics·2017

Area of Science:

  • Biochemistry
  • Endocrinology
  • Orthopedics

Background:

  • Beta2-microglobulin (B2M) is recognized as a potential biomarker for bone remodeling.
  • Tartrate-resistant acid phosphatase (TRAP) is a specific marker for bone resorption.

Purpose of the Study:

  • To evaluate beta2-microglobulin (B2M) and TRAP as biochemical markers of bone remodeling.
  • To compare B2M and TRAP levels in healthy women and patients with conditions of enhanced bone turnover, including Paget's disease.

Main Methods:

  • Measured serum B2M and TRAP in 225 women across different health statuses: premenopausal, postmenopausal, osteoporosis, hyperparathyroidism, hyperthyroidism, and Paget's disease.
  • Analyzed B2M and TRAP levels before and after calcitonin treatment in a subset of patients.

Related Experiment Videos

Main Results:

  • B2M levels were significantly lower in healthy premenopausal women compared to all other groups.
  • TRAP levels differed significantly across most groups, except between Paget's disease and hyperparathyroidism/hyperthyroidism.
  • Calcitonin treatment led to significant increases in B2M and decreases in TRAP and alkaline phosphatase.

Conclusions:

  • Serum B2M, similar to osteocalcin, functions as a bone remodeling marker in several diseases with high bone turnover.
  • B2M is not a reliable marker for bone remodeling specifically in Paget's bone disease.
  • TRAP demonstrated differential levels across various bone remodeling states, with notable exceptions in specific disease comparisons.